2 No-Brainer Healthcare Stocks to Buy Now
The obesity drug market is creating trillion-dollar winners, but you don't have to pay premium prices for exposure. (NYSE: PFE) and Viking Therapeutics (NASDAQ: VKTX) are both relatively inexpensive compared to their opportunities in obesity. One offers a high-yield blue chip that just spent $10 billion entering the space, while the other is a pure-play biotech with late-stage programs in both injectable and oral weight-loss drugs.
Here's why these two healthcare stocks scan as no-brainer buys right now.
Image source: Getty Images.
Source Fool.com
Pfizer Inc. Stock
€21.19
-1.920%
With 14 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
With a target price of 27 € there is a positive potential of 27.45% for Pfizer Inc. compared to the current price of 21.19 €.
